Amgen update: defendants’ “invented” rule for securities fraud class actions Rejected
The securities fraud defense bar had quite a bad day at the Supreme Court this week. By a 6-3 decision in Amgen, the Court rejected the defendants’ newfangled theory that would have required securities fraud plaintiffs to prove materiality to … Continue reading